Application
Western blot analysis of UBAC2 Antibody (N-term) in mouse cerebellum tissue lysates (35ug/lane).UBAC2 (arrow) was detected using the purified Pab.Application
UBAC2 Antibody (N-term) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | UBAC2 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | UBAC2; PHGDHL1; Ubiquitin-associated domain-containing protein 2; Phosphoglycerate dehydrogenase-like protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | PHGDHL1 |
|---|---|
| Alternative Names | UBAC2 PHGDHL1 Ubiquitin-associated domain-containing protein 2 Phosphoglycerate dehydrogenase-like protein 1 |
| Molecular Weight(MW) | 38964 Da |
| Tissue Specificity | This UBAC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 71-101 amino acids from the N-terminal region of human UBAC2. |
| Cellular Localization | Membrane; Multi-pass membrane protein (Potential) |
| Entrez Gene | 337867 |
|---|
Application
Western blot analysis of UBAC2 Antibody (N-term) in mouse cerebellum tissue lysates (35ug/lane).UBAC2 (arrow) was detected using the purified Pab.
Application
UBAC2 Antibody (N-term) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
